Concentrix Corporation (NASDAQ:CNXC), a global provider of customer experience and technology solutions, reported financial results for its fiscal first quarter ended February 28, 2026. The company delivered revenue and non-GAAP earnings per share that fell within its own pre-announced guidance ranges but came in below Wall Street's more optimistic expectations. This discrepancy, coupled with a significant year-over-year decline in GAAP profitability, appears to be driving a negative market reaction, with the stock indicated sharply lower in pre-market trading.
Quarterly Performance Versus Estimates
The first quarter presented a mixed picture when measured against analyst forecasts. While the company met its own targets, it fell short of the broader market's estimates.
- Revenue: Reported revenue of $2.50 billion represented a 5.4% increase year-over-year. However, this figure missed the analyst consensus estimate of $2.54 billion.
- Earnings Per Share (Non-GAAP): The company reported non-GAAP diluted EPS of $2.61. This also came in below the analyst estimate of $2.70 per share.
On a constant currency basis, which removes the impact of foreign exchange fluctuations, revenue growth was a more modest 1.9%. The company highlighted strong momentum in enterprise wins for its iX Suite of integrated technology solutions.
Market Reaction and Profitability Pressures
The market's immediate response to the report was negative, with the stock down approximately 7.5% in pre-market activity. This reaction likely stems from the earnings miss and underlying pressures on profitability evident in the GAAP results.
A closer look at the income statement reveals a challenging quarter for bottom-line growth. While revenue increased, cost of revenue rose at a faster pace (9%), leading to a slight contraction in gross profit. A significant increase in "Other expense, net" – which included foreign currency losses and debt extinguishment costs – further pressured earnings. Consequently, GAAP net income plummeted 69.3% year-over-year to $21.6 million, with GAAP diluted EPS falling to $0.33 from $1.04 in the prior year period.
The company's non-GAAP metrics, which adjust for items like acquisition costs, amortization, and share-based compensation, presented a healthier but still declining picture. Non-GAAP operating income decreased 8.2%, and adjusted EBITDA margin contracted by 190 basis points to 13.9%.
Forward Guidance Versus Analyst Expectations
Management provided its outlook for the second quarter and reaffirmed its full-year fiscal 2026 expectations. A comparison with the provided analyst estimates shows the company's internal forecasts are currently more conservative than the street's projections.
For Q2 Fiscal 2026, Concentrix expects:
- Revenue between $2.460 billion and $2.485 billion.
- Non-GAAP diluted EPS in the range of $2.57 to $2.69.
- Comparison: The midpoint of the revenue guidance ($2.473B) is below the analyst sales estimate of $2.54 billion for Q2. The EPS guidance midpoint is also below the provided consensus.
For Full-Year Fiscal 2026, the company expects:
- Revenue between $10.035 billion and $10.180 billion.
- Non-GAAP diluted EPS between $11.48 and $12.07.
- Adjusted free cash flow of $630 million to $650 million.
- Comparison: The revenue guidance midpoint ($10.11B) is meaningfully lower than the analyst sales estimate of $10.33 billion for the full year.
Capital Allocation and Balance Sheet
The company continued its shareholder return program during the quarter.
- It paid a quarterly dividend of $0.36 per share and declared another of the same amount for May.
- It repurchased approximately 1 million shares for $42.0 million, leaving $396.6 million available under its current authorization.
The balance sheet shows a notable shift in debt maturity, with the current portion of long-term debt increasing to $750 million as of February 28, 2026, up from $65.6 million at the end of the previous quarter, reflecting upcoming maturities.
Conclusion
Concentrix's first-quarter results underscore a period of modest growth and margin compression. While the business continues to generate significant revenue and adjusted cash flow, its performance and forward guidance failed to meet the higher bar set by analyst expectations. The market's negative reaction highlights investor concern over the earnings miss and the company's cautious outlook for the remainder of the fiscal year. The focus will now shift to the company's ability to convert its pipeline of iX Suite wins into accelerated, profitable growth in the coming quarters.
For a detailed look at historical earnings and future analyst projections, you can review the earnings history and current estimates for Concentrix.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, nor does it recommend buying or selling any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.